Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
15.71
-0.12 (-0.76%)
At close: Nov 5, 2026, 4:00 PM EST
15.65
-0.06 (-0.38%)
Pre-market: Nov 6, 2026, 7:08 AM EST
Perrigo Company Market Cap
Perrigo Company has a market cap or net worth of $2.18 billion as of November 5, 2026. It is the 6,180th most valuable company in the world and the 1,680th biggest in the United States. Its market cap has decreased by 21.50% in one year.
Market Cap
2.18B
Enterprise Value
5.21B
1-Year Change
-21.50%
Global Rank
Country Rank
#1,680 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Perrigo Company's market cap has increased from $622.50M to $2.18B, an increase of 250.29%. That is a compound annual growth rate of 4.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 2.18B | 13.83% |
| Dec 31, 2025 | 1.92B | -45.38% |
| Dec 31, 2024 | 3.51B | -19.56% |
| Dec 29, 2023 | 4.36B | -5.00% |
| Dec 30, 2022 | 4.59B | -11.80% |
| Dec 31, 2021 | 5.20B | -14.75% |
| Dec 31, 2020 | 6.10B | -13.19% |
| Dec 31, 2019 | 7.03B | 33.57% |
| Dec 31, 2018 | 5.26B | -57.12% |
| Dec 29, 2017 | 12.28B | 2.87% |
| Dec 30, 2016 | 11.93B | -43.67% |
| Dec 31, 2015 | 21.18B | -5.39% |
| Dec 31, 2014 | 22.39B | 54.74% |
| Dec 31, 2013 | 14.47B | 48.17% |
| Dec 31, 2012 | 9.77B | 7.71% |
| Dec 30, 2011 | 9.07B | 55.24% |
| Dec 31, 2010 | 5.84B | 60.58% |
| Dec 31, 2009 | 3.64B | 22.02% |
| Dec 31, 2008 | 2.98B | -8.90% |
| Dec 31, 2007 | 3.27B | 104.21% |
| Dec 29, 2006 | 1.60B | 15.06% |
| Dec 30, 2005 | 1.39B | 13.24% |
| Dec 31, 2004 | 1.23B | 11.97% |
| Dec 31, 2003 | 1.10B | 30.33% |
| Dec 31, 2002 | 842.80M | -3.10% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 2.98B |
| Regencell Bioscience Holdings | 2.61B |
| HUTCHMED (China) | 2.47B |
| Xeris Biopharma Holdings | 2.38B |
| Prestige Consumer Healthcare | 2.10B |
| Trulieve Cannabis | 2.10B |
| BioCryst Pharmaceuticals | 1.95B |
| Alvotech | 1.62B |